Clinical trial
A Clinical Study to Evaluate the Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) Tablet With Itraconazole and Rifampin in Healthy Chinese Adult Volunteers
NCT06701136 is registered in ClinicalTrials.gov with Shanghai Jiatan Pharmatech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Evaluate the Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) Tablet With Itraconazole and Rifampin in Healthy Chinese Adult Volunteers
- Lead sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- May 12, 2025
- Completion date
- February 12, 2026
- Enrollment
- 16 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rifampicin-resistant pulmonary tuberculosis patients